Atherosclerosis Early Detection In Type 1 Diabetes Mellitus

Seprian Widasmara, Novi Kurnianingsih, Mohammad Saifur Rohman, Anna Fuji Rahimah


Atherosclerosis continues to be a significant consequence in type I diabetes mellitus (T1DM). Cardiovascular disease, caused by accelerated atherosclerosis, is the leading cause of illness and often premature death in patients with T1DM. Risk management is critical. Patients with T1DM who are at an increased risk include those who are less than 10 years old at the time of diagnosis, have a longer history of diabetes, have microvascular problems, or have several risk factors. It is frequently difficult to evaluate vascular hazard and the degree of atherosclerosis on an individualized level, especially early on.


type I diabetes mellitus; Atherosclerosis; ankle–brachial index

Full Text:



Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Fard HH, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: A systematic review and meta-analysis. Heal Promot Perspect. 2020;10(2):98–115.

Pulungan AB, Annisa D, Imada S. Diabetes Melitus Tipe-1 pada Anak: Situasi di Indonesia dan Tata Laksana (Type 1 diabetes mellitus in children: situation and management in Indonesia). Sari Pediatr. 2019;20(6):392.

Hernández M, López C, Real J, Valls J, Ortega-Martinez de Victoria E, Vázquez F, et al. Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes. Cardiovasc Diabetol. 2017;16(1):1–9.

Couper JJ, Haller MJ, Greenbaum CJ, Ziegler AG, Wherrett DK, Knip M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents. Pediatr Diabetes. 2018;19(July):20–7.

Lee SI, Patel M, Jones CM, Narendran P. Cardiovascular disease and type 1 diabetes: Prevalence, prediction and management in an ageing population. Ther Adv Chronic Dis. 2015;6(6):347–74.

Care D, Suppl SS. 10. Cardiovascular disease and risk management: Standards of medical care in diabetesd2019. Diabetes Care. 2019;42(January):S103–23.

De Ferranti SD, De Boer IH, Fonseca V, Fox CS, Golden SH, Lavie CJ, et al. Type 1 diabetes mellitus and cardiovascular disease a scientific statement from the american heart association andamerican diabetes association. Circulation. 2014;130(13):1110–30.

Jenkins A, Januszewski A, O’Neal D. The early detection of atherosclerosis in type 1 diabetes: Why, how and what to do about it. Cardiovasc Endocrinol Metab. 2019;8(1):14–27.

Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson A-M, Miftaraj M, et al. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. N Engl J Med. 2017;376(15):1407–18.

Matuleviciene-Anängen V, Rosengren A, Svensson AM, Pivodic A, Gudbjörnsdottir S, Wedel H, et al. Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes. Heart. 2017;103(21):1687–95.

Mautner SL, Lin F, Roberts WC. Composition of atherosclerotic plaques in the epicardial coronary arteries in juvenile (Type I) diabetes mellitus. Am J Cardiol. 1992;70(15):1264–8.

Djaberi R, Schuijf JD, Boersma E, Kroft LJM, Pereira AM, Romijn JA, et al. Differences in atherosclerotic plaque burden and morphology between type 1 and 2 diabetes as assessed by multislice computed tomography. Diabetes Care. 2009;32(8):1507–12.

Orchard TJ, Backlund JYC, Costacou T, Cleary P, Lopes-Virella M, Levy AP, et al. Haptoglobin 2–2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). J Diabetes Complications [Internet]. 2016;30(8):1577–84. Available from:

Harjutsalo V, Thomas MC, Forsblom C, Groop PH. Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes. Diabetes, Obes Metab. 2018;20(12):2759–67.

Rawshani A, Sattar N, Franzén S, Rawshani A, Hattersley AT, Svensson AM, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018;392(10146):477–86.

Mala S, Potockova V, Hoskovcova L, Pithova P, Brabec M, Kulhankova J, et al. Cardiac autonomic neuropathy may play a role in pathogenesis of atherosclerosis in type 1 diabetes mellitus. Diabetes Res Clin Pract [Internet]. 2017;134:139–44. Available from:

Ganjali S, Dallinga-Thie GM, Simental-Mendía LE, Banach M, Pirro M, Sahebkar A. HDL functionality in type 1 diabetes. Atherosclerosis [Internet]. 2017;267:99–109. Available from:

Llauradó G, Amigó N, Cano A, Ballesta S, Albert L, Mazarico I, et al. Specific nuclear magnetic resonance lipoprotein subclass profiles and central arterial stiffness in type 1 diabetes mellitus: A case control study. J Clin Med. 2019;8(11):1–17.

Virk SA, Donaghue KC, Cho YH, Benitez-Aguirre P, Hing S, Pryke A, et al. Association between HbA1c variability and risk of microvascular complications in adolescents with type 1 diabetes. J Clin Endocrinol Metab. 2016;101(9):3257–63.

Lithovius R, Gordin D, Forsblom C, Saraheimo M, Harjutsalo V, Groop PH. Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes. Diabetologia. 2018;61(9):1935–45.

Ferreira I, Hovind P, Schalkwijk CG, Parving HH, Stehouwer CDA, Rossing P. Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort. Diabetologia. 2018;61(1):231–41.

Odermarsky M, Pesonen E, Sorsa T, Lernmark Å, Pussinen PJ, Liuba P. HLA, infections and inflammation in early stages of atherosclerosis in children with type 1 diabetes. Acta Diabetol. 2018;55(1):41–7.

Margeirsdottir HD, Stensaeth KH, Larsen JR, Brunborg C, Dahl-Jørgensen K. Early signs of atherosclerosis in diabetic children on intensive insulin treatment: A population-based study. Diabetes Care. 2010;33(9):2043–8.

Lilje C, Cronan JC, Schwartzenburg EJ, Owers EM, Clesi P, Gomez R, et al. Intima-media thickness at different arterial segments in pediatric type 1 diabetes patients and its relationship with advanced glycation end products. Pediatr Diabetes. 2018;19(3):450–6.

Järvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, et al. Endothelial Dysfunction and Increased Arterial Intima-Media Thickness in Children with Type 1 Diabetes. Circulation. 2004;109(14):1750–5.

Burge MR, Eaton RP, Schade DS. The Role of a Coronary Artery Calcium Scan in Type 1 Diabetes. Diabetes Technol Ther. 2016;18(9):594–603.

Mehta SR et al. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes. N Engl J Med. 2015;687–96.

Tougaard NH, Theilade S, Winther SA, Tofte N, Ahluwalia TS, Hansen TW, et al. Carotid-femoral pulse wave velocity as a risk marker for development of complications in type 1 diabetes mellitus. J Am Heart Assoc. 2020;9(19).

Nattero-Chávez L, Redondo López S, Alonso Díaz S, Garnica Ureña M, Fernández-Durán E, Escobar-Morreale HF, et al. The peripheral atherosclerotic profile in patients with type 1 diabetes warrants a thorough vascular assessment of asymptomatic patients. Diabetes Metab Res Rev. 2019;35(2).

Donaghue KC, Marcovecchio ML, Wadwa RP, Chew EY, Wong TY, Calliari LE, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes. 2018;19:262–74.



  • There are currently no refbacks.

Copyright (c) 2022 Seprian Widasmara, Novi Kurnianingsih

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.